DPIIT recognised startup Government of India
Startup India
Cathartic Pharmaceuticals Private Limited
Cathartic Pharmaceuticals Private Limited - pharma in Panchkula, Haryana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹31.33 Lakh
▲ 77% YoY
Net profit · FY 2024
₹1.08 Lakh
Net margin 3.4%
EBITDA · FY 2024
₹1.56 Lakh
EBITDA margin 5%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Cathartic Pharmaceuticals Private Limited
Data last updated:
Cathartic Pharmaceuticals Private Limited is a private limited company based in Panchkula, Haryana, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U74999HR2018PTC072979. Its GSTIN is 06AAHCC4543N1ZE (Haryana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anil Kumar and Geeta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shed No. 483 Phase 1 Industrial Area, Panchkula, Haryana, India – 134113.
As per the financials filed for FY 2024, the company reported a revenue of ₹31.33 Lakh, a growth of 77% compared to the previous year. For the same year it recorded a net profit of ₹1.08 Lakh (net margin 3.4%) and EBITDA of ₹1.56 Lakh (EBITDA margin 5%). Revenue has grown at a compounded annual rate (CAGR) of 20% over three years and 70% over five years.
Company details
CIN U74999HR2018PTC072979
Registration Number 072979
Incorporation Date 12 March 2018
ROC Haryana
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Anil Kumar Director Geeta Director Recognitions & Rankings of Cathartic Pharmaceuticals
Contact details
Cathartic Pharmaceuticals Private Limited's registered office is in Panchkula, Haryana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressShed No. 483 Phase 1 Industrial Area, Panchkula, Haryana, India – 134113
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Cathartic Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Cathartic Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cathartic Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cathartic Pharmaceuticals Private Limited, buy the company report.
Financials of Cathartic Pharmaceuticals Private Limited
FY 2025 filings availableCathartic Pharmaceuticals Private Limited reported revenue of ₹31.33 Lakh (up 77% YoY) for FY 2024.
Revenue · FY 2024
₹31.33 Lakh ▲ 77%
Net profit · FY 2024
₹1.08 Lakh margin 3.4%
EBITDA · FY 2024
₹1.56 Lakh margin 5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 77%
3 years · compounded
▲ 20%
5 years · compounded
▲ 70%
EBITDA CAGR growth
1 year
▲ 70%
3 years · compounded
▲ 16%
5 years · compounded
▲ 29%
Revenue has grown at a compounded annual rate (CAGR) of 70% over five years, including 77% growth in the latest year. EBITDA rose 70% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.56 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.08 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5% | ||||
| Net Profit Margin | 3.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cathartic Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cathartic Pharmaceuticals Private Limited
Cathartic Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Also directs: Yanksan Healthcare Private Limited | Director | 12 Mar 2018 | 8 Years 7 Months | Current |
| Geeta Also directs: Yanksan Healthcare Private Limited | Director | 12 Mar 2018 | 8 Years 7 Months | Current |
Peer comparison
Cathartic Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bemaxx Pharmaceuticals Private Limited | ₹31.34 Lakh (FY 2024) | 12.0% | Chennai, Tamil Nadu, India | |||
| Cathartic Pharmaceuticals Private Limitedthis company | ₹31.33 Lakh (FY 2024) | ₹1.08 Lakh | 3.4% | 77.0% | Panchkula, Haryana, India | |
| Styron Pharmaceuticals Private Limited | ₹31.32 Lakh (FY 2025) | 52.0% | Agra, Uttar Pradesh, India | |||
| Nuera Pharmaceuticals Private Limited | ₹31.23 Lakh (FY 2025) | 73.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Cathartic Pharmaceuticals Private Limited, buy the company report.
Auditor
Cathartic Pharmaceuticals Private Limited is audited by RT and Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RT and Associates | FY 2023 | 033729N |
Shareholding
The shareholding of Cathartic Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Cathartic Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cathartic Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cathartic Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cathartic Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCC4543N1ZE | Haryana | Active | 13 Apr 2018 |
To see the full GST registrations and return filing status of Cathartic Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cathartic Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Anil Kumar was appointed as Director on 12 Mar 2018.
AGM
Cathartic Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cathartic Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Haryana.
Appointed
Anil Kumar was appointed as Director.
Appointed
Geeta was appointed as Director.
Incorporation
12 Mar 2018
Cathartic Pharmaceuticals Private Limited was registered on 12 Mar 2018 with Roc Haryana & aged 8 years 7 months as per MCA records.
Frequently asked questions
Cathartic Pharmaceuticals is an active private limited company based in Panchkula, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 March 2018 (8+ years old) and is registered under CIN U74999HR2018PTC072979.
Cathartic Pharmaceuticals has 2 current directors:
- Anil Kumar - Director
- Geeta - Director
The latest financial statements of Cathartic Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Cathartic Pharmaceuticals is 06AAHCC4543N1ZE, registered in Haryana.
The CIN (Corporate Identification Number) of Cathartic Pharmaceuticals is U74999HR2018PTC072979. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cathartic Pharmaceuticals was incorporated on 12 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Cathartic Pharmaceuticals by revenue are Bemaxx Pharmaceuticals Private Limited, Styron Pharmaceuticals Private Limited, Nuera Pharmaceuticals Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Anil Kumar was appointed as Director on 12 Mar 2018. Geeta was appointed as Director on 12 Mar 2018.
Yes, Cathartic Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
The registered office of Cathartic Pharmaceuticals is at Shed No. 483 Phase 1 Industrial Area, Panchkula, Haryana, India – 134113.
Cathartic Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages